AnalystsYoung LiYoung Li's Stock Forecasts
AnalystsYoung Li
Analyst Ranking
Bottom 20%
#4045 out of 4989 analysts
Average Return
-31.42%
Win Rate
33%1 out of 3
Risk vs Reward
Poor
Good
Young Li's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Enovis CorpENOV | +9.43% | $45.08 | $49.33 | 2022‑10‑11 - 2023‑10‑11 | Strong Buy |
Young Li Analyst Color
Get additional color on Young Li's coverage of popular stocks
Young Li's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rxsight IncRXST | 2 | Hold | $9.00 | +6.51% | Downgrades | a month ago |
Cooper Companies IncCOO | 1 | Strong Buy | $115.00 | N/A | Upgrades | a year ago |
Hyperfine IncHYPR | 1 | Hold | $1.25 | N/A | Initiates Coverage On | 2 years ago |
Viewray IncVRAYQ | 1 | Hold | $1.25 | N/A | Downgrades | 2 years ago |
Enovis CorpENOV | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 3 years ago |
Anika Therapeutics IncANIK | 1 | Hold | $46.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.